- Home
- ABEO vs JMIA Comparison
ABEO vs JMIA Comparison
Compare ABEO & JMIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- JMIA
- Stock Information
- Founded
- ABEO 1974
- JMIA 2012
- Country
- ABEO United States
- JMIA Germany
- Employees
- ABEO N/A
- JMIA N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- JMIA Catalog/Specialty Distribution
- Sector
- ABEO Health Care
- JMIA Consumer Discretionary
- Exchange
- ABEO Nasdaq
- JMIA Nasdaq
- Market Cap
- ABEO 256.9M
- JMIA 297.6M
- IPO Year
- ABEO 1980
- JMIA 2019
- Fundamental
- Price
- ABEO $6.24
- JMIA $3.34
- Analyst Decision
- ABEO Strong Buy
- JMIA Buy
- Analyst Count
- ABEO 5
- JMIA 2
- Target Price
- ABEO $17.80
- JMIA $7.88
- AVG Volume (30 Days)
- ABEO 1.7M
- JMIA 3.4M
- Earning Date
- ABEO 05-15-2025
- JMIA 05-08-2025
- Dividend Yield
- ABEO N/A
- JMIA N/A
- EPS Growth
- ABEO N/A
- JMIA N/A
- EPS
- ABEO N/A
- JMIA N/A
- Revenue
- ABEO N/A
- JMIA $154,854,000.00
- Revenue This Year
- ABEO N/A
- JMIA $12.94
- Revenue Next Year
- ABEO $383.07
- JMIA $3.94
- P/E Ratio
- ABEO N/A
- JMIA N/A
- Revenue Growth
- ABEO N/A
- JMIA N/A
- 52 Week Low
- ABEO $3.93
- JMIA $1.60
- 52 Week High
- ABEO $7.32
- JMIA $15.04
- Technical
- Relative Strength Index (RSI)
- ABEO 56.57
- JMIA 60.24
- Support Level
- ABEO $5.93
- JMIA $2.89
- Resistance Level
- ABEO $7.17
- JMIA $3.47
- Average True Range (ATR)
- ABEO 0.44
- JMIA 0.24
- MACD
- ABEO -0.01
- JMIA -0.00
- Stochastic Oscillator
- ABEO 50.00
- JMIA 61.90
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.